From our survey

When your partner's doctor has the final word: a St. Charles FAQ

If you share a home in St. Charles with someone whose depression has outlasted one medication after another, you probably have more questions than anyone has had time to answer. This FAQ collects the ones spouses and partners ask most, with a particular focus on a finding that reshapes the whole effort: for most people, the decisive voice on trying something new is their doctor's.

The poll numbers cited below come from a June survey our publisher commissioned, with 443 adults from ten Midwest states taking part. Since it sampled the general public rather than couples, each percentage speaks for everyone who answered, and each is a final, validated figure.

My partner will not listen to me. Is that unusual?

Not at all, and it may not be about you. The poll asked people which messenger would persuade them to try ketamine or esketamine for depression. A person's own physician won in a rout, cited by 74 percent. The friends-and-family category, where a spouse belongs, got 18 percent. Everything else was single digits: 4 percent for veterans or first responders followed online, 2 percent for ads, and 1 percent for podcasters.

So the typical person weighs a doctor's word about four times as heavily as a loved one's. Your partner tuning you out on this topic is, statistically, the normal pattern.

Then what is the point of me saying anything?

Second place is still a strong position, and it far outpaces advertising and influencers. Your voice is best spent on getting your partner to that first appointment and making it a good one. Think of yourself as the person who opens the door, not the one who closes the deal.

How do I raise the appointment without starting a fight?

Pick a calm time. Describe what you have seen, not what they should do. Something like:

"You have seemed really worn down for months. I would feel better if your doctor knew how hard it has been. Can I help set that up?"

Offer concrete help, like booking the visit or driving, and accept a "not yet" without turning it into a standoff.

Where should the first appointment be?

Usually with their primary care doctor. Most people in the poll, 56 percent, said that is where they would go first. In the St. Louis TV market, which takes in St. Charles, the small group of 31 respondents picked primary care first at 61 percent. A primary doctor can check for medical causes, review medications, and refer to psychiatry. Twenty-three percent of respondents said they would head straight to a psychiatrist or other mental health professional, which is also a reasonable route, particularly if your partner already has one.

What should we bring?

A short written history. List each antidepressant, rough dose, how long it was taken, and what happened. Add therapy, sleep changes, work impact, alcohol use, and other medications. With that page in hand, a doctor can tell whether standard care has truly been exhausted, and that answer decides which doors are open.

Can I come into the exam room?

If your partner wants you there, yes. They can also sign an authorization allowing the office to discuss their care with you. If they would rather go in alone, respect that, and offer to drive and wait.

What if the doctor never brings up newer options?

Your partner can ask. A symptom-first question works well: "The last two medications did not help enough. What would you suggest next?" If the doctor does not handle newer treatments, a psychiatry referral is the usual next step.

What is esketamine, in plain terms?

Esketamine is the active ingredient in Spravato, a nasal spray. Its FDA approval is for adults who have cycled through standard antidepressants without enough relief. Treatment happens only in certified healthcare settings. After each dose the patient stays for observation, typically about two hours, and is told to stay off the road until tomorrow. PTSD is not among its approved uses. Brain Recovery Centers covers Spravato's schedule and monitoring in more depth.

Awareness is thin. In the poll, 73 percent of respondents did not know the Spravato name, and a mere 6 percent could say what it is.

Is it what those ketamine clinic ads are selling?

No. IV ketamine clinics use generic ketamine off-label for depression, usually on a cash basis. At-home ketamine companies prescribe lozenges or tablets through telehealth, also off-label, taken without supervision. Spravato is the one with FDA approval for depression. It matters to people: in the poll, FDA approval would weigh heavily, or settle the question, for 59 percent weighing a treatment.

Will I need to drive?

If Spravato is prescribed, someone must take your partner home after every visit. Early treatment usually means more frequent visits. If you both work, sit down with your calendars before the first appointment. Ask the clinic about its earliest and latest slots, and whether it accepts rideshare pickups.

How do we handle insurance?

Call the member number on the card. Find out if esketamine is on the plan, what the prior authorization steps look like, and which certified sites near St. Charles the plan counts as in network. Coverage beat every other consideration in the poll; a top-two slot went to coverage for 85 percent of respondents. If your partner is on MO HealthNet, their managed care plan can identify in-network psychiatrists.

Is there support for me?

Yes, and you deserve it. Many employers offer free counseling through an assistance program. Family support groups meet in St. Charles County and online. You are also in large company: 72 percent of poll respondents reported that depression, anxiety, or PTSD resistant to standard medication had affected them, someone close, or both.

Is this medical advice?

No. This is general information. No treatment works for everyone, and what suits your partner is a clinician's decision.

If you are ever afraid your partner might harm themselves, trust that fear and act. Text or dial 988 for the Suicide and Crisis Lifeline, where counselors help worried spouses think clearly in the moment. For immediate danger, 911.

Methodology

The publisher commissioned this poll and covered its expense, and Pollfish ran it on its consumer panel, wrapping up June 23, 2026, by which time n=443 respondents aged 18 to 64 had answered from Iowa, Illinois, Kansas, Missouri, Nebraska, Wisconsin, Oklahoma, Ohio, Minnesota, and Indiana. Spouses were not a separate reporting group, and the figures are final after Pollfish validated them.